FDA OKs 3D mode for Biospace Med's EOS

French digital radiography developer Biospace Med of Paris has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a 3D skeletal reconstruction mode for its EOS digital x-ray system.

sterEOS is designed to enable EOS to perform 3D skeletal reconstructions for applications such as visualizing spine pathologies and hip and knee arthropathies. The EOS system captures head-to-toe images of patients in a standing, weight-bearing position at reduced radiation dose. The system received FDA clearance in 2007.

sterEOS includes a 3D visualization workstation and is designed to reduce surgical planning time and help establish an effective course of treatment.

Related Reading

Biospace adds Latin American distributor, November 30, 2007

Biospace raises $18 million, November 27, 2007

Biospace adds to executive lineup, November 19, 2007

Road to RSNA, Digital X-Ray, Biospace Med, October 23, 2007

Biospace Med nets FDA OK on x-ray imager, October 9, 2007

Copyright © 2008 AuntMinnie.com

Page 1 of 1235
Next Page